Experimental Therapeutics Centre (ETC)

Objectives

The Experimental Therapeutics Centre (ETC) was set up to play an increasingly important role in translating scientific discoveries into practical applications. From engaging in early stage drug discovery and development, to developing innovative research tools for clinical analysis, as well as setting up public-private partnerships to facilitate the advancement of drug candidates, ETC will augment Singapore’s capabilities and resources in this spectrum of the drug discovery process.

Activities

ETC plans to achieve the following goals:

  1. Maximising the potential for new discoveries and technologies for human health
  2. Mentoring young scientists for successful careers in the biomedical industry
  3. Managing projects to populate a successful product pipeline

Leadership

The management team, led by CEO Professor Sir David Lane, is drawn from industry and academia. A corporate structure with experienced management and scientific oversight has been set up to facilitate the discovery, development and pre-clinical evaluation of potential diagnostics and therapeutics.

 

 

For more information on the Experimental Therapeutics Centre (ETC), please refer to http://www.etc.a-star.edu.sg.